MedPath

Study of antifungal drug susceptibility in fungal infections of the ski

Not Applicable
Conditions
Health Condition 1: null- Superficial dermatophyte infections of the skin
Registration Number
CTRI/2014/11/005219
Lead Sponsor
IADV
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
80
Inclusion Criteria

All patients clinically diagnosed to be suffering from superficial dermatophytosis

Exclusion Criteria

1. Clinical evidence of superadded bacterial infection

2. Patients not consenting to provide a sample

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Identifying the causative agents responsible for dermatophyte infections in Mumbai, India <br/ ><br>2. To determine the minimum inhibitory concentration values( MIC 50 & MIC 80 ) OF THE FOLLOWING DRUGS : Terbinafine, Griseofulvin, Fluconazole, Itraconazole, Ketoconazole, Clotrimazole and Sertaconazole against these dermatophytesTimepoint: One Year
Secondary Outcome Measures
NameTimeMethod
To select the best antifungal drug for a patient of Dermatophytosis. thereby reducing the disease morbidityTimepoint: 1year
© Copyright 2025. All Rights Reserved by MedPath